Leveraging Process Analytical Technology For Developing Novel Conjugates

This webinar on Process Analytical Technology (PAT) offers a comprehensive exploration of how this innovative approach is transforming the development and manufacturing of novel conjugates, particularly in the biopharmaceutical space. Gain valuable insights into the strategic advantages of integrating PAT into process development workflows, with a focus on its role in enhancing efficiency, data quality, and overall product consistency. Learn how MilliporeSigma, a leading Contract Development and Manufacturing Organization (CDMO), utilizes its advanced Antibody-Drug Conjugate (ADC) platform to support the creation of a diverse array of novel conjugates. By embedding PAT into their development processes, MilliporeSigma is able to deepen process understanding, streamline data collection, and significantly reduce the number of development runs required—ultimately accelerating timelines and improving outcomes.

Find out how leveraging a robust ADC platform in combination with PAT not only speeds up process development but also ensures the delivery of high-quality therapeutics from the outset.